SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claud B who wrote (2883)3/21/1998 1:33:00 PM
From: Hank  Read Replies (1) of 7041
 
If their clinical trials have long been finished, then why haven't they submitted their NDA? They should be right on PFE's heals and hyping the product all the way just like PFE has been doing with Viagra. If in fact they have collected all the clinical data on Vasomax that they ever intend to, then it just convinces me even more that SGP no longer believes that Vasomax will get FDA approval. This is not the way to compete in a highly competitive market place like pharmaceuticals.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News